Heart valve prosthesis
By setting up a variety of capsule pocket structures in the heart valve prosthesis, the sealing of the valve and blood flow erosion of the valve are solved, and the risk of valve leakage and thrombosis in the prior art is improved, and the treatment effect and safety of patients are improved.
Patent Information
- Application Number
- CN202420043424.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-01-08
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2034-01-08
AI Technical Summary
The blood leakage problem of existing heart valve prosthesis in the middle of the valve leads to valve heart leakage. Especially in elderly patients with multiple organ diseases or poor heart function, traditional surgical procedures are at high risk and transcatheter replacement/repair. There is a high risk of blood flow stagnation and thrombosis.
A heart valve prosthesis is designed, including a stent, artificial valvular leaflet and capsule. The vacuole is provided with a central vacuole, a communicating vacuole, a bottom vacuole and a circumferential vacuole of the valve, through which The expansion and collapsed state of the bag is sealed and flushed when the leaflets are opened and closed, reducing the risk of leakage and thrombosis.
It effectively reduces leakage through the center of the valve, reduces the risk of thrombosis of artificial valve leaves in the communicating and bottom, improves the sealing of the valve to the native tissue, reduces perival leakage, and improves the patient's chance of recovery.
Smart Images

Figure CN221963831U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of medical instruments, in particular to a heart valve prosthesis with a capsule. Background Art
[0002] The heart contains four chambers, the left atrium and left ventricle are located on the left side of the heart, and the right atrium and right ventricle are located on the right side of the heart. The ventricular inflow tract is formed between the atrium and the ventricle, the left ventricular outflow tract is formed between the left ventricle and the aorta, and the right ventricle and the pulmonary artery form the right ventricular outflow tract. There are valves with "one-way valve" functions at the ventricular inflow tract and ventricular outflow tract to ensure the normal flow of blood in the heart chamber. When there is a problem with the valve, the heart hemodynamics changes and the heart function is abnormal, which is called valvular heart disease. With the development of social economy and the aging of the population, the incidence of valvular heart disease has increased significantly. Studies have shown that the incidence of valvular heart disease in the elderly population over 75 years old is as high as 13.3%. At present, traditional surgical treatment is still the first choice for patients with severe valvular disease, but for patients of advanced age, combined with multiple organ diseases, with a history of open-chest surgery, and poor heart function, traditional surgical treatment has high risks and mortality, and some patients do not even have the opportunity for surgery. Transcatheter valve replacement / repair has the advantages of no need for thoracotomy, less trauma, and quick patient recovery, and has attracted extensive attention from experts and scholars. However, existing heart valve prostheses can cause valve leakage, which is mainly caused by blood leakage in the middle of the valve due to poor closure after the valve is closed. Utility Model Content
[0003] In view of the defects of the prior art, the utility model provides a heart valve prosthesis, which can reduce leakage through the center of the valve by arranging a valve leaflet center bag.
[0004] To achieve the above-mentioned purpose, the utility model provides a heart valve prosthesis, which has an inflow end and an outflow end, and comprises: a stent, an artificial valve leaflet and a capsule; the artificial valve leaflet is fixed inside the stent; the capsule is connected to the stent; the capsule comprises a valve leaflet central pocket, the valve leaflet central pocket has a central pocket notch facing the outflow end; the valve leaflet central pocket is arranged on the axis of the artificial valve leaflet when it is closed;
[0005] The central bag of the leaflet has an expanded state and a collapsed state; the central bag of the leaflet is in the collapsed state when the artificial leaflet is opened; the central bag of the leaflet is in the expanded state and contacts the artificial leaflet to seal the artificial leaflet when the artificial leaflet is closed.
[0006] Optionally, the capsule body further includes a leaflet central capsule frame, which is respectively connected to the leaflet central pocket and the support, and the leaflet central pocket is located at the top of the leaflet central capsule frame away from the inflow end.
[0007] Optionally, the leaflet central capsule frame is a slender rod.
[0008] Optionally, the bag body further comprises a commissure bag, the commissure bag having a commissure bag notch facing the outflow end; the commissure bag is arranged at the commissure of two adjacent artificial valve leaflets;
[0009] The commissure bag has an expanded state and a collapsed state; the commissure bag is in the collapsed state when the artificial valve leaflet is opened; the commissure bag is in the expanded state and contacts the adjacent artificial valve leaflet for sealing when the artificial valve leaflet is closed.
[0010] Optionally, the endothelialization rate of the commissure pouch is greater than, equal to, or less than the endothelialization rate of the leaflet center pouch.
[0011] Optionally, the bag body further includes a leaflet bottom bag, the leaflet bottom bag having a leaflet bottom bag notch facing the outflow end; the leaflet bottom bag is arranged corresponding to the bottom area of the artificial leaflet and is located outside the artificial leaflet; the bottom area of the artificial leaflet is not connected to the stent;
[0012] The leaflet bottom bag has an expanded state and a collapsed state; the leaflet bottom bag is in the collapsed state when the artificial leaflet is opened and forms a flow channel with the bottom area; the leaflet bottom bag is in the expanded state when the artificial leaflet is closed and contacts the artificial leaflet to close the flow channel.
[0013] Optionally, the maximum outer diameter of the leaflet bottom bag along the length direction of the fixed side of the artificial leaflet in the expanded state is less than or equal to 1 / 2 of the total length of the fixed side.
[0014] Optionally, the leaflet bottom bag can fit tightly against the target object in the expanded state.
[0015] Optionally, the porosity of the side of the leaflet bottom pouch away from the artificial leaflet is greater than the porosity of the other side close to the artificial leaflet, and / or the endothelialization rate of the side of the leaflet bottom pouch away from the artificial leaflet is greater than the endothelialization rate of the other side close to the artificial leaflet.
[0016] Optionally, the side of the leaflet bottom bag away from the artificial leaflet is made of a material selected from the group consisting of polyethylene terephthalate, polyvinyl pyrrolidone, polylactic acid and polycaprolactone, and the side of the leaflet bottom bag close to the artificial leaflet is made of a material selected from the group consisting of polyurethane, polytetrafluoroethylene and polyethylene.
[0017] Optionally, the bag body further comprises a valve circumferential bag, the valve circumferential bag having a valve circumferential bag notch facing the outflow end; the valve circumferential bag is arranged along the entire circumference of the heart valve prosthesis;
[0018] The valve circumferential bag has an expanded state and a collapsed state; the valve circumferential bag is in the collapsed state and forms a gap with the target object when the artificial valve leaflet is opened; the valve circumferential bag is in the expanded state and fits the target object when the artificial valve leaflet is closed.
[0019] Optionally, the valve circumferential pouch is disposed near the inflow end and is at least partially disposed on the outside of the stent.
[0020] Optionally, the endothelialization rate of the circumferential pocket of the valve is greater than the endothelialization rate of the central pocket of the valve leaflet.
[0021] Compared with the prior art, the heart valve prosthesis provided by the utility model has at least the following advantages:
[0022] The above-mentioned heart valve prosthesis also has its own bag body, which is connected to the bracket, and the bag body at least includes a leaflet central bag, and the leaflet central bag has a central bag notch facing the outflow end; the leaflet central bag is arranged on the axis when the artificial leaflet is closed; the leaflet central bag has an expanded state and a collapsed state; the leaflet central bag is in the collapsed state when the artificial leaflet is opened; the leaflet central bag is in the expanded state and contacts with the artificial leaflet when the artificial leaflet is closed to seal the artificial leaflet; this is conducive to reducing leakage through the valve center.
[0023] The sac body may also include a commissure bag, the commissure bag having a commissure bag notch facing the outflow end; the commissure bag is disposed at the commissure of two adjacent artificial valve leaflets; the commissure bag has an expanded state and a collapsed state; the commissure bag is in the collapsed state when the artificial valve leaflets are opened; the commissure bag is in the expanded state and contacts the adjacent artificial valve leaflets for sealing when the artificial valve leaflets are closed. With such a configuration, the commissures of adjacent artificial valve leaflets can be completely flushed by blood flow, avoiding blood flow stagnation and thrombosis, thereby reducing the risk of thrombosis at the commissures of the artificial valve leaflets.
[0024] The bag body may further include a leaflet bottom bag, the leaflet bottom bag having a leaflet bottom bag notch facing the outflow end; the leaflet bottom bag is arranged corresponding to the bottom area of the artificial leaflet and is located outside the artificial leaflet; the bottom area of the artificial leaflet is not connected to the support; the leaflet bottom bag has an expanded state and a collapsed state; the leaflet bottom bag is in the collapsed state when the artificial leaflet is opened and forms a flow channel with the bottom area; the leaflet bottom bag is in the expanded state when the artificial leaflet is closed and contacts the artificial leaflet to close the flow channel. Such a configuration is conducive to flushing the bottom dead area of the artificial leaflet, reducing the risk of thrombosis, and at the same time, when the valve is closed, it can reduce paravalvular leakage.
[0025] The capsule body may further include a valve circumferential bag, the valve circumferential bag having a valve circumferential bag notch facing the outflow end; the valve circumferential bag is arranged along the entire circumference of the heart valve prosthesis; the valve circumferential bag has an expanded state and a collapsed state; the valve circumferential bag is in the collapsed state when the artificial valve leaflet is opened and forms a gap between the target object; the valve circumferential bag is in the expanded state and fits the target object (i.e., native tissue) when the artificial valve leaflet is closed. In this way, the gap between the valve and the native tissue can be reduced, thereby reducing paravalvular leakage. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Those skilled in the art will understand that the drawings provided are for a better understanding of the present invention and do not constitute any limitation on the scope of the present invention, and that the "tissue" in the drawings refers to native tissue.
[0027] Figure 1 It is a schematic diagram of the overall structure of a heart valve prosthesis provided according to an embodiment of the utility model;
[0028] Figure 2 It is a schematic diagram of the top view of the closed heart valve prosthesis provided according to one embodiment of the utility model;
[0029] Figure 3 is a schematic diagram of a top view of the heart valve prosthesis when it is opened according to a comparative embodiment;
[0030] Figure 4 is a schematic diagram of a top view of the heart valve prosthesis when closed according to a comparative embodiment;
[0031] Figure 5 It is a schematic diagram of a top view of the structure of a heart valve prosthesis provided according to an embodiment of the utility model when a commissure bag is provided at the commissure when the heart valve prosthesis is opened, wherein the commissure bag is in a collapsed state;
[0032] Figure 6 It is a schematic diagram of a top view of the structure of a heart valve prosthesis provided according to an embodiment of the utility model when a commissure bag is provided at the commissure when the heart valve prosthesis is closed, wherein the commissure bag is in an expanded state;
[0033] Figure 7 It is a partial structural schematic diagram of a heart valve prosthesis provided according to an embodiment of the utility model when a commissure bag is provided at the commissure when the heart valve prosthesis is opened, wherein the arrow indicates the blood flow direction when the blood flows from the inflow end to the outflow end when the heart valve prosthesis is opened;
[0034] Figure 8 is a schematic diagram of the structure of the commissure bag in a collapsed state according to an embodiment of the utility model, wherein the arrow indicates the direction of blood flow when the heart valve prosthesis is opened and the blood flows from the inflow end to the outflow end;
[0035] Fig. 9 is a schematic structural diagram of a commissure bag in an expanded state according to an embodiment of the utility model, wherein the arrow indicates the reverse flow direction of blood flow when the heart valve prosthesis is closed;
[0036] Fig.10 It is a schematic diagram of various shapes of the joint bag provided according to an embodiment of the utility model;
[0037] Fig.11 It is a state diagram of a heart valve prosthesis provided in a comparative embodiment, in which blood will flow back when the prosthesis is closed, and a dead zone of blood flow stagnation is easily formed at the bottom of the artificial valve leaflet;
[0038] Fig.12 This is a state diagram of a heart valve prosthesis provided in a comparative embodiment, in which blood in the dead zone forms a thrombus because the blood cannot be flushed away in time when the heart valve prosthesis is opened;
[0039] Fig.13 It is a structural schematic diagram of a heart valve prosthesis provided according to an embodiment of the utility model, in which a valve leaflet bottom pocket is provided in the bottom area of the artificial valve leaflet;
[0040] Fig.14 It is a schematic diagram of a state in which a flow channel is formed between a bag at the bottom of a valve leaflet and a bottom area of an artificial valve leaflet when a heart valve prosthesis provided by an embodiment of the utility model is opened;
[0041] Fig.15 It is a structural schematic diagram of a valve leaflet bottom bag in a collapsed state according to an embodiment of the utility model;
[0042] Fig.16 It is a schematic diagram of a state in which a heart valve prosthesis provided according to an embodiment of the utility model expands a bag at the bottom of the valve leaflet and closes the flow channel when the heart valve prosthesis is closed;
[0043] Fig.17 It is a structural schematic diagram of a valve leaflet bottom bag in an expanded state according to an embodiment of the utility model;
[0044] Fig.18 It is a structural schematic diagram of a heart valve prosthesis provided according to an embodiment of the utility model, in which a valve circumferential pocket is arranged at the periphery close to the inflow end;
[0045] Fig.19 It is a schematic diagram of a state in which a gap is formed between the circumferential pocket of the valve and the native tissue when the heart valve prosthesis provided by one embodiment of the utility model is opened;
[0046] Fig. 20 It is a schematic diagram of a state in which the heart valve prosthesis provided according to an embodiment of the utility model fills the gap between the prosthesis and the native tissue in the circumferential pocket of the valve when the heart valve prosthesis is closed;
[0047] Fig.21 It is a schematic diagram of the structure of the leaflet center pouch provided according to an embodiment of the utility model;
[0048] Fig. 22 It is a structural schematic diagram of a heart valve prosthesis provided according to an embodiment of the utility model, in which the central bag of the valve leaflet is in a collapsed state when the heart valve prosthesis is opened;
[0049] Fig.23 It is a structural schematic diagram of a heart valve prosthesis provided according to an embodiment of the utility model, in which the central bag of the valve leaflet is in an expanded state when the valve leaflet is closed.
[0050] The reference numerals are described as follows:
[0051] 100-heart valve prosthesis; 110-stent; 120-skirt; 130-artificial valve leaflet; 140-suture; 150-capsule; 151-commissure bag; 1511-commissure bag notch; 152-leaflet bottom bag; 1521-leaflet bottom bag notch; 153-valve circumferential bag; 1531-valve circumferential bag notch; 154-leaflet central bag; 1541-central bag notch; 155-leaflet central bag frame. DETAILED DESCRIPTION
[0052] In order to make the purpose, advantages and features of the utility model clearer, the utility model is further described in detail below in conjunction with the accompanying drawings and specific embodiments. It should be noted that the drawings are all in a very simplified form and are not drawn to scale, and are only used to conveniently and clearly assist in explaining the purpose of the embodiments of the utility model. In addition, the structure shown in the drawings is often a part of the actual structure. In particular, the emphasis of each drawing is different, and sometimes different scales are used.
[0053] As used in the present invention, the singular forms "one", "an" and "the" include plural objects, the term "or" is usually used to include the meaning of "and / or", the term "several" is usually used to include the meaning of "at least one", and the term "at least two" is usually used to include the meaning of "two or more". In addition, the terms "first" and "second" are only used for descriptive purposes and cannot be understood as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Therefore, the features defined as "first" and "second" may explicitly or implicitly include one or at least two of the features, the terms "one end" and "the other end" generally refer to two corresponding parts, which not only include endpoints, and the terms "installed", "connected" and "connected" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral one; it can be a mechanical connection, a direct connection, or an indirect connection through an intermediate medium, and it can be the internal connection of two elements or the interaction relationship between two elements. In addition, as used in the present invention, an element disposed on another element generally only indicates that there is a connection, coupling, cooperation or transmission relationship between the two elements, and the connection, coupling, cooperation or transmission between the two elements may be direct or indirect through an intermediate element, and cannot be understood as indicating or implying the spatial position relationship between the two elements, that is, an element may be in any orientation such as inside, outside, above, below or on one side of another element, unless otherwise clearly indicated in the content. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.
[0054] The "outer diameter" described herein corresponds to the diameter size for a circular structure, and for a non-circular structure, the outer diameter refers to the diameter of its circumscribed circle; the "axial direction" corresponds to the direction of the central axis of a cylindrical structure, and for a non-cylindrical structure, the axial direction corresponds to the length direction of the extension path. The term "axial direction" described herein refers to the direction of the central axis of the heart valve prosthesis, "circumferential direction" refers to the direction around the central axis of the heart valve prosthesis, and "radial direction" refers to the direction perpendicular to the axial direction of the heart valve prosthesis.
[0055] The utility model aims to provide a heart valve prosthesis, which improves the performance of the heart valve prosthesis by arranging at least one of a commissure pocket, a leaflet bottom pocket, a valve circumferential pocket and a leaflet center pocket.
[0056] The heart valve prosthesis provided by the utility model can be transformed between a radially compressed state and a radially expanded state. The heart valve prosthesis is folded on the delivery system in a radially compressed state during delivery, and after reaching the implantation site, it is separated from the delivery system and expanded to a radially expanded state. It should be understood that the heart valve prosthesis provided by the present application can be used with various delivery systems and can be implanted via various delivery methods.
[0057] The heart valve prosthesis provided by the utility model can be suitable for implantation into natural aortic valve, pulmonary valve, mitral valve and tricuspid valve.
[0058] The following description is made with reference to the accompanying drawings. It can be understood by those skilled in the art that, under the premise of no conflict, the following preferred embodiments can be freely combined and superimposed.
[0059] Please refer to Figure 1 and Figure 2 As shown, the embodiment of the present application provides a heart valve prosthesis 100, having an inflow end and an outflow end opposite to each other. Figure 1 From the placement position, the upper part is the outflow end of the heart valve prosthesis 100, and the lower part is the inflow end of the heart valve prosthesis 100.
[0060] The heart valve prosthesis 100 includes a stent 110, an artificial valve leaflet 130 and a capsule 150. The heart valve prosthesis 100 generally also includes a skirt 120, which can be sutured on the stent 110 as a sealing component. The skirt 120 may include at least one of an inner skirt and an outer skirt. The skirt 120 may be fully wrapped around the circumference of the stent 110 to effectively prevent paravalvular leakage. The stent 110, the artificial valve leaflet 130 and the skirt 120 are connected as a whole and to each other mainly by sutures 140. The material of the suture 140 is not limited, for example, various known conventional materials such as PTFE (polytetrafluoroethylene), ePTFE (expanded polytetrafluoroethylene), PE (polyethylene) and the like may be selected.
[0061] The stent 110 can provide several functions for the heart valve prosthesis 100, including: serving as the main structure of the valve; carrying the internal artificial valve leaflet 130; connecting structure with the delivery system (hanging ears or fixing ears), etc. The stent 110 is an annular frame that can be woven or cut, without limitation. The stent 110 can be made of various suitable materials. Optionally, the stent 110 is made of materials such as nickel-titanium alloy, titanium alloy, cobalt-chromium alloy, MP35n, 316 stainless steel, or a biocompatible metal frame made of other biocompatible metals known to those skilled in the art, or a laser-cut solid metal tube, preferably nickel-titanium material. The stent 110 can also be made of elastically or plastically deformable materials, such as balloon-expandable materials.
[0062] The skirt 120 can be made of knitted, woven or braided polyester fabric, such as PTFE (polytetrafluoroethylene), ePTFE (expanded polytetrafluoroethylene) and other materials.
[0063] The artificial valve leaflet 130 is fixed inside the stent 110; the artificial valve leaflet 130 can dynamically switch between the open and closed states. The artificial valve leaflet 130 is tightened or converged in a sealed abutment manner in the closed state. The artificial valve leaflet 130 can be selected from biological tissue, such as chemically stable tissue from the heart valve of an animal (such as a pig), or animal pericardial tissue such as cattle (bovine pericardium) or sheep (sheep pericardium) or pig (porcine pericardium) or horse (equine pericardium), preferably bovine pericardial tissue. The artificial valve leaflet 130 can also be made of submucosal tissue of the small intestine.
[0064] Please refer to Figure 3 and Figure 4 As shown, at the commissure 1 of adjacent artificial valve leaflets 130, when the artificial valve leaflets 130 are opened and closed, a part of the commissure 1 is always in contact, the blood flow velocity near this area is low, and the macromolecules in the blood cannot be washed away well, which makes it easy to form thrombus. Return to reference Figure 1 and Figure 2 In order to reduce the risk of thrombosis of the artificial valve leaflet 130 at the commissure 1 , the heart valve prosthesis 100 further includes a capsule 150 .
[0065] The material of the capsule 150 may be a biological tissue material, such as a chemically stable tissue from the heart valve of an animal (such as a pig), or an animal pericardial tissue such as a cow (bovine pericardium) or a sheep (sheep pericardium) or a pig (pig pericardium) or a horse (equine pericardium), or a polymer material such as PET (polyethylene terephthalate), PTFE (polytetrafluoroethylene), PU (polyurethane), PE (polyethylene), PVP (polyvinyl pyrrolidone), PLA (polylactic acid), PCL (polycaprolactone), etc. The specific material of the capsule 150 is not limited. The capsule 150 is connected to the stent 110 by suturing, bonding or other methods, and the connection method is not limited. It should be noted that in the following description, any bag contained in the capsule 150 needs to be connected to the stent 110.
[0066] In one embodiment, the capsule 150 includes a joint bag 151, and the joint bag 151 has a joint bag notch 1511 facing the outflow end (see Figure 8 to Figure 10 The joint pouch 151 is a bag with a cavity. The joint pouch 151 has an expanded state and a collapsed state, and can be switched between the collapsed state and the expanded state.
[0067] Please refer to Figure 5 and Figure 6As shown, the commissure pocket 151 is disposed at the commissure 1 of two adjacent artificial valve leaflets 130 , so that the commissure pocket 151 is directly between the commissures 1 of the adjacent artificial valve leaflets 130 . The commissure pocket 151 can be used to separate two adjacent artificial valve leaflets 130 .
[0068] Please combine 5. Figure 7 and Figure 8 As shown, when the artificial valve leaflet 130 is opened, the joint bag 151 is in a collapsed state, so that the joint 1 of the adjacent artificial valve leaflet 130 can be easily washed completely by the blood flow, avoiding blood flow stagnation, thereby reducing the risk of thrombosis at the joint 1.
[0069] Combined with Figure 6 and Fig. 9 As shown, when the artificial valve leaflet 130 is closed, the commissure bag 151 expands under the action of reverse blood flow pressure and contacts the adjacent artificial valve leaflet 130 to perform a sealing function and reduce leakage.
[0070] like Fig.10 As shown in (a)-(e) of FIG. 1 , the joint bag 151 can have various shapes, such as teardrop-shaped, rectangular, semicircular, etc. Preferably, the joint bag 151 is teardrop-shaped, which not only saves materials but also has better anti-thrombotic and sealing effects.
[0071] In some embodiments, the commissure pouch 151 has a large commissure pouch notch 1511 (i.e., a large opening), such as Fig.10 In some other embodiments, the joint pouch 151 has a plurality of small joint pouch notches 1511, such as Fig.10 The shape of the joint pocket notch 1511 is not limited, including but not limited to the circular and rectangular shapes described in the figure.
[0072] The commissure pockets 151 may be disposed on the inner side and the outer side of the stent 110 , or partially disposed on the inner side of the stent 110 and partially disposed on the outer side of the stent 110 .
[0073] Preferably, the commissure pouch 151 is made of various suitable low endothelialization materials, which is conducive to further reducing the risk of thrombosis in the commissure 1. The commissure pouch 151 can be selected from PU (polyurethane), PTFE (polytetrafluoroethylene), PE (polyethylene) or other known materials with relatively slow endothelialization speed. The commissure pouch 151 can be made of one or more combined materials.
[0074] It has also been found that when the artificial valve leaflet 130 is closed, blood Fig.11 The middle arrow indicates the direction of backflow, which is likely to form a backflow vortex at the bottom of the artificial valve leaflet 130, resulting in a dead zone of blood flow stagnation; Fig.12As shown in FIG. 1 , when the artificial valve leaflet 130 is opened, the blood macromolecules in the dead zone cannot be flushed away in time, and then a thrombus is formed. Fig.13 As shown, in one embodiment, the capsule 150 further includes a leaflet bottom bag 152, and the leaflet bottom bag 152 also has a leaflet bottom bag notch 1521 facing the outflow end (see Fig.15 and Fig.17 ); The leaflet bottom pouch 152 is arranged corresponding to the bottom area of the artificial leaflet 130, and is located on the outside of the artificial leaflet 130. At the same time, the bottom area of the artificial leaflet 130 is not connected to the stent 110. The leaflet bottom pouch 152 is arranged circumferentially along the bottom area of the artificial leaflet 130, and can be distributed at the center position of the bottom area or at a position offset from the center. The center of the bottom area refers to the position closest to the inflow end, and the size of the bottom area should be selected as much as possible so as not to reduce the strength of the connection between the artificial leaflet 130 and the stent 110 and not to cause the collapse of the artificial leaflet 130.
[0075] The leaflet bottom bag 152 has an expanded state and a collapsed state, and can be switched between the collapsed state and the expanded state.
[0076] Please refer to Fig.14 and Fig.15 As shown, when the artificial valve leaflet 130 is opened, the valve leaflet bottom bag 152 is in a collapsed state, and a flow channel A is formed between the bottom area of the artificial valve leaflet 130 and the valve leaflet bottom bag 152, that is, the flow channel A is formed between the inner side of the valve leaflet bottom bag 152 and the outer side of the artificial valve leaflet 130, so that the blood flow can flush the "dead area" through this flow channel A, reducing the risk of thrombosis at the bottom of the artificial valve leaflet 130. For ease of understanding, Fig.16 The dotted line a in the figure shows that the bottom area of the artificial valve leaflet 130 corresponds to the position of the valve leaflet bottom bag 152 which is not connected to the stent 110.
[0077] On the contrary, if Fig.16 and Fig.17 As shown, when the artificial valve leaflet 130 is closed, the bag 152 at the bottom of the valve leaflet is in an expanded state under the reverse pressure of blood flow, so that the bag 152 at the bottom of the valve leaflet is in full contact with the outer side of the artificial valve leaflet 130, thereby closing the original flow channel A and preventing blood leakage.
[0078] The bag 152 at the bottom of the leaflet should not be too large or too small; if it is too large, it is easy to reduce the connection strength between the artificial leaflet 130 and the stent 110, causing the artificial leaflet 130 to collapse; if it is too small, the effect is not obvious. In this regard, preferably, the maximum outer diameter of the bag 152 at the bottom of the leaflet along the length direction of the fixed edge of the artificial leaflet 130 when in the expanded state is less than or equal to 1 / 2 of the total length of the fixed edge, or in other words, the center angle α of the bag 152 at the bottom of the leaflet along the length direction of the fixed edge of the artificial leaflet 130 when in the expanded state is ≤1 / 2β, β is the center angle of the fixed edge of the artificial leaflet 130; this can better ensure that when the artificial leaflet 130 is closed, the connection strength between the artificial leaflet 130 and the stent 110 is large enough to avoid the problem of collapse of the artificial leaflet 130. The center angle α refers to the center angle of the arc between the two ends of the fixed side length direction of the valve leaflet bottom bag 152, and the center angle β refers to the center angle of the arc between the two ends of the fixed side of a single artificial valve leaflet 130 in the length direction, and the center is the center of the artificial valve leaflet 130 when it is closed. It should be further explained that the structure of the artificial valve leaflet 130 (including the fixed side and the joint part) can be understood by those skilled in the art with reference to the prior art, and no detailed description is given.
[0079] Continue to refer to Fig.14 The leaflet bottom bag 152 is arranged at a position corresponding to the bottom area of the artificial leaflet 130, specifically at the outside of the bottom area, and can overlap with the bottom area to form a flow channel A when the artificial leaflet 130 is opened. At the same time, the size of the leaflet bottom bag 152 after expansion needs to ensure that it can contact the outside of the artificial leaflet 130 for sealing.
[0080] Preferably, the leaflet bottom pocket 152 can fit more closely with the native tissue when in the expanded state (see Fig.16 ), reducing the gap between the valve and native tissue and reducing paravalvular leakage.
[0081] Preferably, the porosity of the side of the valve leaflet bottom bag 152 away from the artificial valve leaflet 130 is greater than the porosity of the other side close to the artificial valve leaflet 130. In this way, the valve leaflet bottom bag 152 is conducive to reducing the risk of thrombosis on the side close to the artificial valve leaflet 130, and can be endothelialized quickly on the side close to the native tissue, ensuring that the valve leaflet bottom bag 152 is closely attached to the native tissue.
[0082] Preferably, the endothelialization speed of the side of the leaflet bottom pocket 152 away from the artificial leaflet 130 is greater than the endothelialization speed of the other side close to the artificial leaflet 130, which can also prevent thrombosis and promote endothelialization.
[0083] In this embodiment, the leaflet bottom pouch 152 uses a material with a large porosity and a relatively fast endothelialization speed on the side close to the native tissue, and uses a material with a relatively slow endothelialization speed on the side away from the native tissue. Optionally, the leaflet bottom pouch 152 uses PET (polyethylene terephthalate), PVP (polyvinyl pyrrolidone), PLA (polylactic acid), PCL (polycaprolactone) or other known materials with a relatively fast endothelialization speed on the side close to the native tissue (i.e., the far side away from the artificial leaflet 130), and the leaflet bottom pouch 152 uses PU (polyurethane), PTFE (polytetrafluoroethylene), PE (polyethylene) or other known materials with a relatively slow endothelialization speed on the side away from the native tissue. The leaflet bottom pouch 152 can be prepared by one or more combinations of these materials.
[0084] The shape of the leaflet bottom bag 152 after expansion is not limited, and can be a variety of shapes, such as a teardrop shape, a rectangle, a semicircle, etc., preferably a teardrop shape. The leaflet bottom bag 152 has one leaflet bottom bag notch 1521 or multiple leaflet bottom bag notches 1521, which is not limited. There is no special requirement for the shape of the leaflet bottom bag notch 1521, for example, it can be a circle, a rectangle or other various shapes.
[0085] It should be understood that the bottom area of each artificial leaflet 130 is provided with a leaflet bottom pocket 152. The leaflet bottom pocket 152 can be provided inside or outside the stent 110, or the leaflet bottom pocket 152 is partially provided inside the stent 110 and partially provided outside the stent 110.
[0086] Please refer to Figures 18 to 20 As shown, in one embodiment, the capsule 150 further includes a valve circumferential sac bag 153, and the valve circumferential sac bag 153 has a valve circumferential sac bag notch 1531 facing the outflow end to facilitate collapse and expansion. The valve circumferential sac bag 153 is arranged along the entire circumference of the heart valve prosthesis 100. Preferably, the valve circumferential sac bag 153 is arranged at a position close to the inflow end. The valve circumferential sac bag 153 is at least partially arranged on the outside of the stent 110, and more preferably, the entire valve circumferential sac bag 153 is arranged around the stent 110 on the outside of the stent 110. The valve circumferential sac bag 153 can be a bag arranged continuously along the entire circumference, or a plurality of independent bags arranged at intervals along the circumference. Correspondingly, the valve circumferential sac bag notch 1531 can be a large opening or a plurality of independent small openings. The valve circumferential sac bag notch 1531 can be any suitable shape such as a circle, a rectangle, etc., and this application is not limited to this.
[0087] The valve circumferential bag 153 has an expanded state and a collapsed state. Fig.19As shown, when the artificial valve leaflet 130 is opened, the valve circumferential bag 153 is in a collapsed state and forms a gap with the native tissue, so that blood flow can partially pass through the gap between the valve circumferential bag 153 and the native tissue. Fig. 20 As shown, when the artificial valve leaflet 130 is closed, the valve circumferential bag 153 can fit closely with the native tissue when in an expanded state, so that the valve circumferential bag 153 fills the gap between the heart valve prosthesis 100 and the native tissue, reducing paravalvular leakage.
[0088] As a preferred embodiment, the bag body 150 includes a commissure bag 151 , a leaflet bottom bag 152 and a valve circumferential bag 153 , wherein the leaflet bottom bag 152 is farther away from the inflow end than the valve circumferential bag 153 .
[0089] Preferably, the valve circumferential pouch 153 is made of a material with a large porosity and a good endothelialization effect, such as PET (polyethylene terephthalate), PVP (polyvinyl pyrrolidone), PLA (polylactic acid), PCL (polycaprolactone) or other known materials with a relatively fast endothelialization speed, and is prepared by a combination of one or more of these materials. In particular, it is considered that the endothelialization speed of the valve circumferential pouch 153 is greater than the endothelialization speed of the commissure pouch 151, and (or) the endothelialization speed of the valve circumferential pouch 153 is greater than the endothelialization speed of the leaflet center pouch 154 described below.
[0090] The valve circumferential pocket 153 can have a variety of shapes, schematically, teardrop-shaped, rectangular, semicircular, etc., preferably teardrop-shaped.
[0091] Return to reference Figure 1 , and combined with Figure 21 to Figure 23 As shown, in yet another embodiment, the capsule 150 may include a leaflet central pocket 154. Fig.23 As shown, the leaflet central pocket 154 has a central pocket notch 1541 facing the outflow end, and the central pocket notch 1541 can be one or more, and the shape of the central pocket notch 1541 is not limited; the leaflet central pocket 154 is arranged on the axis when the artificial leaflet 130 is closed. The leaflet central pocket 154 also has an expanded state and a collapsed state.
[0092] refer to Fig. 22 As shown, when the artificial valve leaflets 130 are opened, the valve leaflet central pocket 154 is in a collapsed state. At this time, each artificial valve leaflet 130 is outwardly away from the valve leaflet central pocket 154 and does not contact the valve leaflet central pocket 154, so that blood can flow through the heart valve prosthesis 100. Fig.23As shown, when the artificial leaflet 130 is closed, the leaflet center bag 154 is in an expanded state, and each artificial leaflet 130 is in full contact with the leaflet center bag 154, which plays a sealing role and reduces leakage through the center of the valve.
[0093] Furthermore, the capsule 150 further includes a leaflet central capsule frame 155, which is respectively connected to the leaflet central pouch 154 and the support 110, and the leaflet central pouch 154 is located at the top of the leaflet central pouch frame 155 away from the inflow end. In this way, the leaflet central pouch frame 155 plays a role in supporting the leaflet central pouch 154, and this structure is simple and will not affect the blood flow through the valve.
[0094] The leaflet central capsule frame 155 can be set at the center position of the heart valve prosthesis 100 or off-center position, and there is no special requirement for this, as long as the leaflet central pouch 154 is located on the axis when the artificial leaflet 130 is closed. The leaflet central capsule frame 155 can be any slender rod such as a straight rod or a curved rod, which has a small size and little effect on blood flow. The leaflet central capsule frame 155 can be made of metal, polymer material or composite material. The leaflet central capsule frame 155 can be a hollow tube or a solid rod, preferably a hollow tube.
[0095] The leaflet center pocket 154 may be in a variety of shapes, optionally in some embodiments, such as a teardrop shape, a rectangle, a semicircle, etc., preferably a teardrop shape.
[0096] The endothelialization speed of the leaflet center pouch 154 is less than, equal to, or greater than the endothelialization speed of the commissure pouch 151. In particular, the leaflet center pouch 154 is made of a material with a relatively slow endothelialization speed, and the more commonly used materials are PU (polyurethane), PTFE (polytetrafluoroethylene), PE (polyethylene), etc. The leaflet center pouch 154 can be formed by processing a combination of one or more of these materials.
[0097] In summary, the heart valve prosthesis provided by the utility model has at least the following advantages:
[0098] (1) The commissure pocket 151 allows the commissures 1 of adjacent artificial valve leaflets 130 to be completely flushed by blood flow, thus avoiding blood flow stagnation and thrombosis;
[0099] (2) The valve leaflet bottom pocket 152 can flush the bottom dead area of the artificial valve leaflet 130 to reduce the risk of thrombosis and partially reduce paravalvular leakage when the valve is closed;
[0100] (3) The circumvalvular pocket 153 can reduce the gap between the valve and tissue, thereby reducing paravalvular leakage;
[0101] (4) The leaflet center pocket 154 reduces leakage through the center of the valve.
[0102] The above description is only a description of the preferred embodiment of the utility model, and is not any limitation to the scope of the utility model. Any changes and modifications made by ordinary technicians in the field of the utility model based on the above disclosure shall fall within the protection scope of the technical solution of the utility model.
Claims
1. A heart valve prosthesis having an inflow end and an outflow end, characterized in that: include: A stent, an artificial valve leaflet and a capsule; the artificial valve leaflet is fixed inside the stent; the capsule is connected to the stent; the capsule includes a valve leaflet central capsule bag, the valve leaflet central capsule bag has a central capsule bag notch facing the outflow end; the valve leaflet central capsule bag is arranged on the axis of the artificial valve leaflet when it is closed; The central bag of the leaflet has an expanded state and a collapsed state; the central bag of the leaflet is in the collapsed state when the artificial leaflet is opened; the central bag of the leaflet is in the expanded state and contacts the artificial leaflet to seal the artificial leaflet when the artificial leaflet is closed.
2. The heart valve prosthesis according to claim 1, characterized in that: The capsule body also includes a leaflet central capsule frame, which is respectively connected to the leaflet central pocket and the support, and the leaflet central pocket is located at the top end of the leaflet central capsule frame away from the inflow end.
3. The heart valve prosthesis according to claim 2, characterized in that: The leaflet center capsule frame is a slender rod.
4. The heart valve prosthesis according to claim 1 or 2, characterized in that: The sac body further comprises a commissure sac bag, wherein the commissure sac bag has a commissure sac bag notch facing the outflow end; the commissure sac bag is arranged at the commissure of two adjacent artificial valve leaflets; The commissure bag has an expanded state and a collapsed state; the commissure bag is in the collapsed state when the artificial valve leaflet is opened; the commissure bag is in the expanded state and contacts the adjacent artificial valve leaflet for sealing when the artificial valve leaflet is closed.
5. The heart valve prosthesis according to claim 4, characterized in that: The endothelialization rate of the commissure pocket is greater than, equal to, or less than the endothelialization rate of the leaflet center pocket.
6. The heart valve prosthesis according to claim 1 or 2, characterized in that: The bag body also includes a leaflet bottom bag, the leaflet bottom bag has a leaflet bottom bag notch facing the outflow end; the leaflet bottom bag is arranged corresponding to the bottom area of the artificial leaflet and is located outside the artificial leaflet; the bottom area of the artificial leaflet is not connected to the bracket; The leaflet bottom bag has an expanded state and a collapsed state; the leaflet bottom bag is in the collapsed state when the artificial leaflet is opened and forms a flow channel with the bottom area; the leaflet bottom bag is in the expanded state when the artificial leaflet is closed and contacts the artificial leaflet to close the flow channel.
7. The heart valve prosthesis according to claim 6, characterized in that: The maximum outer diameter of the leaflet bottom bag along the length direction of the fixed side of the artificial leaflet in the expanded state is less than or equal to 1 / 2 of the total length of the fixed side.
8. The heart valve prosthesis according to claim 6, characterized in that: The leaflet bottom bag can fit tightly against the target object in the expanded state.
9. The heart valve prosthesis according to claim 6, characterized in that: The porosity of the side of the leaflet bottom bag away from the artificial leaflet is greater than the porosity of the other side close to the artificial leaflet, and / or the endothelialization rate of the side of the leaflet bottom bag away from the artificial leaflet is greater than the endothelialization rate of the other side close to the artificial leaflet.
10. The heart valve prosthesis according to claim 6, characterized in that: The side of the leaflet bottom bag away from the artificial leaflet is made of a material selected from the group consisting of polyethylene terephthalate, polyvinyl pyrrolidone, polylactic acid and polycaprolactone, and the side of the leaflet bottom bag close to the artificial leaflet is made of a material selected from the group consisting of polyurethane, polytetrafluoroethylene and polyethylene.
11. The heart valve prosthesis according to claim 1 or 2, characterized in that: The sac body further comprises a valve circumferential sac bag, wherein the valve circumferential sac bag has a valve circumferential sac bag notch facing the outflow end; the valve circumferential sac bag is arranged along the entire circumference of the heart valve prosthesis; The valve circumferential bag has an expanded state and a collapsed state; the valve circumferential bag is in the collapsed state and forms a gap with the target object when the artificial valve leaflet is opened; the valve circumferential bag is in the expanded state and fits the target object when the artificial valve leaflet is closed.
12. The heart valve prosthesis according to claim 11, characterized in that: The valve circumferential pocket is disposed near the inflow end and is at least partially disposed outside the stent.
13. The heart valve prosthesis according to claim 11, characterized in that: The endothelialization rate of the circumferential pocket of the valve is greater than the endothelialization rate of the central pocket of the valve leaflet.
Citation Information
Cited By
Heart valve prosthesis
CN117717441A
